臺灣核心實作指引(TW Core IG)
0.3.2 - Ci-Build Trial Use
臺灣核心實作指引(TW Core IG)
0.3.2 - Ci-Build Trial Use
臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions
臨床狀態：Active ( AllergyIntoleranceClinicalStatusCodes#active)
驗證狀態：Confirmed ( AllergyIntoleranceVerificationStatusCodes#confirmed)
根本原因或運作機制：Allergy ( AllergyIntoleranceType#allergy)
確定的物質的類別：Medication ( AllergyIntoleranceCategory#medication)
嚴重程度：High Risk ( AllergyIntoleranceCriticality#high)
過敏或不耐症的識別：青黴素過敏(Penicillin allergy) ( SNOMED CT#91936005)
過敏或不耐症被識別的時間：2023-10-15T08:45:00
病人：Patient/pat-example "陳加玲"
紀錄者：Practitioner/pra-dr-example "王依昇"
被記錄的日期：2023-10-15T12:00:00
關於過敏的資訊來源：Practitioner/pra-nurse-example "陳莉"
最後一次已知反應發生的日期與時間：2023-12-05T15:30:00
過敏或不耐受物質的不良反應紀錄：
過敏產生的特定物質或醫藥產品：青黴素(Medicinal product containing penicillin and acting as antibacterial agent (product)) ( SNOMED CT#6369005)
與此事件相關的臨床症狀/體徵)：Upper respiratory tract hypersensitivity reaction ( SNOMED CT#490008)
對整個過敏事件的描述：呼吸急促、皮膚發紅
嚴重程度：Severe ( AllergyIntoleranceSeverity#severe)
如何接觸到該物質：口服(Oral use) ( SNOMED CT#26643006)
備註：患者在服用青黴素後出現呼吸急促和皮膚發紅，症狀於2023年10月15日中午12:00發作